These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19890251)
1. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Benjamin DK; Smith PB; Arrieta A; Castro L; Sánchez PJ; Kaufman D; Arnold LJ; Kovanda LL; Sawamoto T; Buell DN; Hope WW; Walsh TJ Clin Pharmacol Ther; 2010 Jan; 87(1):93-9. PubMed ID: 19890251 [TBL] [Abstract][Full Text] [Related]
2. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis. Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of micafungin in neonates and young infants. Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation. Autmizguine J; Hornik CP; Benjamin DK; Brouwer KL; Hupp SR; Cohen-Wolkowiez M; Watt KM Pediatr Infect Dis J; 2016 Nov; 35(11):1204-1210. PubMed ID: 27314826 [TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis. Benjamin DK; Deville JG; Azie N; Kovanda L; Roy M; Wu C; Arrieta A Pediatr Infect Dis J; 2013 Nov; 32(11):e419-25. PubMed ID: 23958810 [TBL] [Abstract][Full Text] [Related]
6. Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits. Petraitiene R; Petraitis V; Hope WW; Walsh TJ Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S643-51. PubMed ID: 26567283 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Smith PB; Walsh TJ; Hope W; Arrieta A; Takada A; Kovanda LL; Kearns GL; Kaufman D; Sawamoto T; Buell DN; Benjamin DK Pediatr Infect Dis J; 2009 May; 28(5):412-5. PubMed ID: 19319022 [TBL] [Abstract][Full Text] [Related]
8. [Why might micafungin be the drug of choice in pediatric patients?]. Ramos Amador JT; Prieto Tato L; Guillén Martín S Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573 [TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients. Martial LC; Ter Heine R; Schouten JA; Hunfeld NG; van Leeuwen HJ; Verweij PE; de Lange DW; Pickkers P; Brüggemann RJ Clin Pharmacokinet; 2017 Oct; 56(10):1197-1206. PubMed ID: 28144840 [TBL] [Abstract][Full Text] [Related]
10. Safety of micafungin in infants: insights into optimal dosing. Ascher S; Smith PB; Benjamin DK Expert Opin Drug Saf; 2011 Mar; 10(2):281-6. PubMed ID: 21226655 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation. Albano E; Azie N; Roy M; Townsend R; Arrieta A J Pediatr Hematol Oncol; 2015 Jan; 37(1):e45-50. PubMed ID: 25072363 [TBL] [Abstract][Full Text] [Related]
17. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia. Andes D; Ambrose PG; Hammel JP; Van Wart SA; Iyer V; Reynolds DK; Buell DN; Kovanda LL; Bhavnani SM Antimicrob Agents Chemother; 2011 May; 55(5):2113-21. PubMed ID: 21300835 [TBL] [Abstract][Full Text] [Related]
18. Echinocandin use in the neonatal intensive care unit. Caudle KE; Inger AG; Butler DR; Rogers PD Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects. Undre NA; Stevenson P; Wilbraham D Int J Clin Pharmacol Ther; 2014 Mar; 52(3):237-44. PubMed ID: 24472403 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis associated with micafungin use in a preterm infant. King KY; Edwards MS; Word BM J Perinatol; 2009 Apr; 29(4):320-2. PubMed ID: 19325554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]